You can buy or sell GRTS and other stocks, options, ETFs, and crypto commission-free!
Gritstone Oncology, Inc. clinical-stage biotechnology company, which engages in developing the next generation of cancer immunotherapies to fight multiple cancer types. The company was founded by Andrew Allen, Timothy Chan, Mark Cobbold, Graham Lord, Naiyer Rizvi and Jean-Charles Soria in August 2015 and is headquartered in Emeryville, CA.
52 Week High
52 Week Low
— per share
Expected Nov 5, Pre-Market